Automated Breast Ultrasound System (ABUS) Market value is projected to reach US$ 1009.66 Mn at the end of the forecast period and it is expected to grow at the CAGR of 14.60%. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Automated Breast Ultrasound System (ABUS) Market Overview:
Breast cancer is the most commonly diagnosed type of cancer detected in women after ’40s. Automated Breast Ultrasound System (ABUS) is a device that uses a transducer to detect breast cancer most efficiently with less time as compared to HHUS [hand held ultrasound system]. Therefore, ABUS can potentially replace HHUS in term of saving time and more accuracy. Increasing awareness of diseases like cancer has resulted in regular check-ups or scanning that boost the demand for ABUS market. A rising incidence of breast cancer is also one of the main reasons behind the increasing market of ABUS. Also, reimbursement policies in countries like US giving demand for Global Automated Breast Ultrasound System (ABUS) Market.Automated Breast Ultrasound System (ABUS) Market Regional analysis
North America has the largest market share with countries like US that hold for maximum regional revenue share. Increasing awareness of cancer increases the number of screenings which results in demand for ABUS market. Adoption of technological advancements and government policies in the US creates the demand for Global Automated Breast Ultrasound System (ABUS) Market. The Asia Pacific excluding Japan is expected as one of the fastest growing ABUS markets due to breast cancer awareness campaigns by governments around the globe. China automated market is expected to increase by USD 400 million by 2029 due to cancer screening awareness at an early stage. ABUS scanners have been classified as prone-type or supine-type scanners. These scanners use various techniques like prone water bath scanning and supine water coupled scanning using 4-7 MHz transducers. ABUS provides 3D images with more detailed structure over 2d images. Automated Breast Ultrasound System (ABUS) provides detection of breast cancer with great accuracy and less time compared to HHUS. ABUS is used by hospital and diagnostic centers to large extent. Dense breast tissue, large consumption of alcohol, genetic hereditary, radiation exposure, obesity are some common reasons among women that leads to breast cancer which will increase screenings of cancer that will increase demand for ABUS. Hospitals and diagnostic centers are major users of ABUS. Use of ABUS in hospitals and diagnostic centers over HHUS provides accuracy in detection with less time. When ABUS is used with mammography increases the accuracy level. Automated Breast Ultrasound System (ABUS) is one of the fastest growing markets with expected 6.6 % in the forecast period. North America will account for maximum share due to raising awareness of diseases and adopted technological advancements. Increasing cancer awareness programs all over the globe fuel the Global Automated Breast Ultrasound System (ABUS) Market.Automated Breast Ultrasound System (ABUS) Market : Inquire before buying
Global Automated Breast Ultrasound System (ABUS) Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US$ 388.94 Mn. Forecast Period 2023 to 2029 CAGR: 14.6% Market Size in 2029: US$ 1009.66 Mn. Segments Covered: by Product Type Prone Supine by End Users Hospitals Diagnostic Centres Ambulatory Care Centres The above data will be provided for following regions/countries (USD Million)
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Automated Breast Ultrasound System (ABUS) Market Key Players are:
1. GE Healthcare 2. Siemens AG 3. Koninklijke Philips N.V. 4. Toshiba Corporation. 5. Hitachi Ltd 6. Hologic 7. Esaote 8. General Electric Company 9. SonoCine Inc. 10.Telemed Medical Systems 11.Canon Medical Systems Corporation 12.Fukuda Denshi 13.Hologic, Inc. 14.Delphinus Medical Technologies, Inc. 15.Nova Medical Imaging Technology Co. Ltd. 16.Seno Medical Instruments 17.iVu Imaging Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Automated Breast Ultrasound System Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Automated Breast Ultrasound System Market? Ans: The Global Market is expected to grow at a CAGR of 14.6% during forecast period 2023-2029. 3. What is scope of the Global market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – GE Healthcare,Siemens AG,Koninklijke Philips N.V.,Toshiba Corporation.,Hitachi Ltd,Hologic,Esaote,General Electric Company,SonoCine Inc.,Telemed Medical Systems,Canon Medical Systems Corporation,Fukuda Denshi,Hologic, Inc.,Delphinus Medical Technologies, Inc.,Nova Medical Imaging Technology Co. Ltd.,Seno Medical Instruments,iVu Imaging Corporation 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
Global Automated Breast Ultrasound System (ABUS) Market
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global ambulatory surgery centers market overview 2.1.1. By product type 2.1.2. By applications 2.1.3. By end user Chapter 3 Automated Breast Ultrasound System (ABUS) 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Automated Breast Ultrasound System is used as diagnostic tool in case of breast cancer. 3.2.1.2. ABUS is more portable as compared to scanners like CT and MRI 3.2.1.3. Rising awareness of breast cancer disease and regular checkups regarding cancer 3.2.1.4. Less time consuming as compared to HHUS 3.2.2. Market restraints 3.2.2.1. In certain circumstances it fails to evaluate axillary lymph nodes and elastrophic capabilities as compared to HHUS 3.2.2.2. Coverage of breast is less 3.3. Market share analysis 3.3.1. By product type 3.3.2. By applications 3.3.3. By end users 3.4. Reimbursements scenario 3.4.1. U.S. 3.5. Regulations landscape 3.5.1. U.S. 3.5.2. Europe 3.6. Competitive analysis 3.6.1. Key strategic initiatives 3.6.2. Regional presence 3.6.3. Product overview 3.7. Porter’s analysis 3.8. PESTEL analysis Chapter 4 Automated Breast Ultrasound System (ABUS) Market, By Product Type 4.1. Key segment trends 4.1.1. Market size, by region, 2022-2029 4.2. Prone 4.2.1. Market size, by region, 2022-2029 4.3. Supine 4.3.1. Market size, by region, 2022-2029 Chapter 5 Automated Breast Ultrasound System (ABUS) Market, By end user 5.1. Key segment trends 5.2. Hospitals 5.2.1. Market size, by region, 2022-2029 5.3. Diagnostic Centers 5.3.1. Market size, by region, 2022-2029 5.4. Research & Academic Institutions 5.4.1. Market size, by region, 2022-2029 Chapter 6 Automated Breast Ultrasound System (ABUS) Market, By Region 6.1. Key regional trends 6.2. North America 6.2.1. Market size, by country, 2022-2029 6.2.2. Market size, by product type, 2022-2029 6.2.3. Market size, by application, 2022-2029 6.2.4. Market size, by end user, 2022-2029 6.2.5. U.S. 6.2.5.1. Market size, by product type, 2022-2029 6.2.5.2. Market size, by application, 2022-2029 6.2.5.3. Market size, by end user, 2022-2029 6.2.6. Canada 6.2.6.1. Market size, by product type, 2022-2029 6.2.6.2. Market size, by application, 2022-2029 6.2.6.3. Market size, by end user, 2022-2029 6.3. Europe 6.3.1. Market size, by country, 2022-2029 6.3.2. Market size, by product type, 2022-2029 6.3.3. Market size, by application, 2022-2029 6.3.4. Market size, by end user, 2022-2029 6.3.5. Germany 6.3.5.1. Market size, by product type, 2022-2029 6.3.5.2. Market size, by application, 2022-2029 6.3.5.3. Market size, by end user, 2022-2029 6.3.6. UK 6.3.6.1. Market size, by product type, 2022-2029 6.3.6.2. Market size, by application, 2022-2029 6.3.6.3. Market size, by end user, 2022-2029 6.3.7. France 6.3.7.1. Market size, by product type, 2022-2029 6.3.7.2. Market size, by application, 2022-2029 6.3.7.3. Market size, by end user, 2022-2029 6.3.8. Spain 6.3.8.1. Market size, by product type, 2022-2029 6.3.8.2. Market size, by application, 2022-2029 6.3.8.3. Market size, by end user, 2022-2029 6.3.9. Italy 6.3.9.1. I Market size, by product type, 2022-2029 6.3.9.2. Market size, by application, 2022-2029 6.3.9.3. Market size, by end user, 2022-2029 6.3.10. Russia 6.3.10.1. Market size, by product type, 2022-2029 6.3.10.2. Market size, by application, 2022-2029 6.3.10.3. Market size, by end user, 2022-2029 6.4. Asia Pacific 6.4.1. Market size, by country, 2022-2029 6.4.2. Market size, by product type, 2022-2029 6.4.3. Market size, by application, 2022-2029 6.4.4. Market size, by end user, 2022-2029 6.4.5. India 6.4.5.1. Market size, by product type, 2022-2029 6.4.5.2. Market size, by application, 2022-2029 6.4.5.3. Market size, by end user, 2022-2029 6.4.6. China 6.4.6.1. Market size, by product type, 2022-2029 6.4.6.2. Market size, by application, 2022-2029 6.4.6.3. Market size, by end user, 2022-2029 6.4.7. Japan 6.4.7.1. Market size, by product type, 2022-2029 6.4.7.2. Market size, by application, 2022-2029 6.4.7.3. Market size, by end user, 2022-2029 6.4.8. Australia 6.4.8.1. Market size, by product type, 2022-2029 6.4.8.2. Market size, by application, 2022-2029 6.4.8.3. Market size, by end user, 2022-2029 6.5. Latin America 6.5.1. Market size, by country, 2022-2029 6.5.2. Market size, By Device Technology, 2022-2029 6.5.3. Market size, by application, 2022-2029 6.5.4. Market size, by end user, 2022-2029 6.5.5. Argentina 6.5.5.1. Market size, by product type, 2022-2029 6.5.5.2. Market size, by application, 2022-2029 6.5.5.3. Market size, by end user, 2022-2029 6.5.6. Brazil 6.5.6.1. Market size, by product type, 2022-2029 6.5.6.2. Market size, by application, 2022-2029 6.5.6.3. Market size, by end user, 2022-2029 6.5.7. Mexico 6.5.7.1. Market size, by product type, 2022-2029 6.5.7.2. 6.5.7.3. Market size, by application, 2022-2029 6.5.7.4. Market size, by end user, 2022-2029 6.6. Middle East and Africa 6.6.1. Market size, by country, 2022-2029 6.6.2. Market size, by product type, 2022-2029 6.6.3. Market size, by application, 2022-2029 6.6.4. Market size, by end user, 2022-2029 6.6.5. South Africa 6.6.5.1. Market size, by product type, 2022-2029 6.6.5.2. Market size, by application, 2022-2029 6.6.5.3. Market size, by end user, 2022-2029 6.6.6. Saudi Arabia 6.6.6.1. Market size, by product type, 2022-2029 6.6.6.2. Market size, by application, 2022-2029 6.6.6.3. Market size, by end user, 2022-2029 Chapter 7 Company Profiles 7.1. GE Healthcare (A Subsidiary of General Electric Company) 7.1.1. Company overview 7.1.2. Key financials 7.1.3. Product landscape 7.1.4. Strategic initiatives 7.1.5. SWOT analysis 7.2. Siemens AG 7.2.1. Company overview 7.2.2. Key financials 7.2.3. Product landscape 7.2.4. Strategic initiatives 7.2.5. SWOT analysis 7.3. Koninklijke Philips N.V. 7.3.1. Company overview 7.3.2. Key financials 7.3.3. Product landscape 7.3.4. Strategic initiatives 7.3.5. SWOT analysis 7.4. Toshiba Corporation. 7.4.1. Company overview 7.4.2. Key financials 7.4.3. Product landscape 7.4.4. Strategic initiatives 7.4.5. SWOT analysis 7.5. Hitachi Ltd 7.5.1. Company overview 7.5.2. Key financials 7.5.3. Product landscape 7.5.4. Strategic initiatives 7.5.5. SWOT analysis 7.6. Hologic 7.6.1. Company overview 7.6.2. Key financials 7.6.3. Product landscape 7.6.4. Strategic initiatives 7.6.5. SWOT analysis 7.7. Esaote 7.7.1. Company overview 7.7.2. Key financials 7.7.3. Product landscape 7.7.4. Strategic initiatives 7.7.5. SWOT analysis 7.8. General Electric Company (U.S 7.8.1. Company overview 7.8.2. Key financials 7.8.3. Product landscape 7.8.4. Strategic initiatives 7.8.5. SWOT analysis 7.9. SonoCine Inc. (U.S.) 7.9.1. Company overview 7.9.2. Key financials 7.9.3. Product landscape 7.9.4. Strategic initiatives 7.9.5. SWOT analysis 7.10. Telemed Medical Systems 7.10.1. Company overview 7.10.2. Key financials 7.10.3. Product landscape 7.10.4. Strategic initiatives 7.10.5. SWOT analysis 7.11. Canon Medical Systems Corporation 7.12. Fukuda Denshi 7.13. Hologic, Inc. 7.14. Delphinus Medical Technologies, Inc. 7.15. Nova Medical Imaging Technology Co. Ltd. 7.16. Seno Medical Instruments 7.17. iVu Imaging Corporation